Cargando…
Kynureninase Upregulation Is a Prominent Feature of NFR2-Activated Cancers and Is Associated with Tumor Immunosuppression and Poor Prognosis
SIMPLE SUMMARY: We previously reported a novel mechanism of NRF2 tumoral immune suppression through selective upregulation of the tryptophan-metabolizing enzyme kynureninase (KYNU) in lung adenocarcinoma. In the current study, we report that elevated tumoral KYNU gene expression is broadly associate...
Autores principales: | León-Letelier, Ricardo A., Abdel Sater, Ali H., Chen, Yihui, Park, Soyoung, Wu, Ranran, Irajizad, Ehsan, Dennison, Jennifer B., Katayama, Hiroyuki, Vykoukal, Jody V., Hanash, Samir, Ostrin, Edwin J., Fahrmann, Johannes F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913753/ https://www.ncbi.nlm.nih.gov/pubmed/36765792 http://dx.doi.org/10.3390/cancers15030834 |
Ejemplares similares
-
Mutational Activation of the NRF2 Pathway Upregulates Kynureninase Resulting in Tumor Immunosuppression and Poor Outcome in Lung Adenocarcinoma
por: Fahrmann, Johannes F., et al.
Publicado: (2022) -
The kynurenine pathway presents multi-faceted metabolic vulnerabilities in cancer
por: León-Letelier, Ricardo A., et al.
Publicado: (2023) -
c-MYC-Driven Polyamine Metabolism in Ovarian Cancer: From Pathogenesis to Early Detection and Therapy
por: Chen, Yihui, et al.
Publicado: (2023) -
Plasma-Derived Extracellular Vesicles Convey Protein Signatures That Reflect Pathophysiology in Lung and Pancreatic Adenocarcinomas
por: Fahrmann, Johannes F., et al.
Publicado: (2020) -
Novel UHRF1-MYC Axis in Acute Lymphoblastic Leukemia
por: Park, Soyoung, et al.
Publicado: (2022)